Join WCH and University of Toronto on Sept. 26 for discussions on the latest evidence on the management of #CardiovascularDisease in #rheumatic patients. This symposium will focus on: #menopause, imaging of the heart, and #WeightLoss strategies. Register today at www.cardiorheum.eventbrite.com

Dr. Touma's study revealed that although the membranous lupus nephritis disease burden is ⬇️ than proliferative lupus nephritis it is not a benign disease and may be associated with deterioration of renal function, end-stage kidney disease and cardiovascular events. pubmed.ncbi.nlm.nih.gov/39133193

Analysis of diagnostic delay in axSpa patients across geographic regions varies considerably, according to a new study by Dr. Poddubnyy and team. The mean diagnostic delay was 7.4 years. Read more here ➡️ pubmed.ncbi.nlm.nih.gov/39321311/ #Rheumatology #axSpa

New study by Dr. Poddubnyy and team → The long-term safety profile of Bimekizumab in adult patients with axSpA or PsA is well tolerated with stable safety profiles and no new safety signals over time. Read Here ➡️ rmdopen.bmj.com/content/11/2... #Rheumatology

Dr. Pagnoux and team released a study on oral health in patients with vasculitis. Frequent oral and dental complications led to significantly impaired oral HRQOL, especially in Takayasu arteritis and Behçet Disease. Read Here ➡️ link.springer.com/article/10.1... #Rheumatology

Dr. Johnson and team demonstrated how quality improvement methods can significantly improve systemic sclerosis quality of care through low cost and applicable interventions. ➡️https://www.jrheum.org/content/52/6/598.long #Rheumatology

A recent study by Dr. Gladman and colleagues sheds light on the development of degenerative disk disease in young patients with PsA. Risk factors include older age, male sex, diabetes mellitus, and inflammatory back pain Read Here ➡️ www.jrheum.org/content/52/6... #rheumatology #psoriaticarthritis

Dr. Gladman and team’s new research highlights that tuft resorption in PsA is associated with more severe disease, including peripheral and axial radiographic damage. DMARDs appear to exert a protective effect against its development www.sciencedirect.com/science/arti... #rheumatology

Join us @ EULAR June 12th speaking about new 🔥 stuff in lupus treatment. #rheumatology #EULAR2025 #lupus

Come listen to a fascinating talk at EULAR in Barcelona by Dr. Dafna Gladman on Wednesday June 11th #rheumatology #psoriaticarthritis

A recent study by Dr. Chandran and team revealed that metabolic syndrome is associated with degenerative and metabolic changes in the spine and entheses but not with axial disease or radiographic damage in PsA #rheumatology #PsA Read here ➡️ acrjournals.onlinelibrary.wiley.com/doi/10.1002/...

A new study by Dr. @lihieder.bsky.social and team found that elevated levels of hsCRP, a biomarker of systemic inflammation, are associated with future risk of PsA development in patients with psoriasis, independent of other known PsA risk factors. acrjournals.onlinelibrary.wiley.com/doi/10.1002/...

Dr. Chandran and team’s study identified the most common skin pain qualities as aching, tender, dull and itchy and were correlated with functional outcomes and disease activity in PsA patients. #rheumatology #PsA Read more ➡️ pubmed.ncbi.nlm.nih.gov/40276787/

Dr. @zahitouma.bsky.social and team recently found that the addition of anifrolumab to the standard of care of SLE is effective at preventing and/or delaying organ damage in patients with moderately to severely active forms of the disease. #lupus #rheumatology www.sciencedirect.com/science/arti...

Dr. Haroon and his team have discovered that non-radiographic axial spondyloarthritis and female patients and those with non-radiographic SpA are more likely to discontinue biologic therapies. #AxSpA #rheumatology Read More Here ➡️https://pubmed.ncbi.nlm.nih.gov/39919972/

Read the paper by Dr. Inman and team where ⬆️ IL-17A–producing cells in secukinumab non-responder AxSpA patients point to a higher inflammatory burden compared to responders. There is ⬆️ immune complexity in AxSpA, emphasizing the need for precision therapeutics. pubmed.ncbi.nlm.nih.gov/39160761/

Dr. Gladman and team found that cigarette smoking does not appear to be significantly associated with the progression of joint damage in Psoriatic arthritis. #rheumatology #PsoriaticArthritis pubmed.ncbi.nlm.nih.gov/39914263/

Dr. Gladman's research provides insights into the cellular heterogeneity of psoriatic arthritis suggesting that TNFAIP3 and NFKBIA related pathways may be deregulated in PsA CD8+ T cells. #rheumatology #PsoriaticArthritis pubmed.ncbi.nlm.nih.gov/39991156/

A new paper by Dr. V. Chandran and team compares early vs. late transition from psoriasis to psoriatic arthritis in terms of PsA phenotype and outcomes. A trend for higher cumulative disease activity was noted with early transition. #rheumatology www.sciencedirect.com/science/arti...

Dr. Kuriya and team’s research revealed that although adherence to heat failure testing quality measures was high, patients with inflammatory arthritis were less likely to receive duideline-directed medical therapy than diabetes patients. #rheumatology www.sciencedirect.com/science/arti...

Our very own Dr. Sindhu Johnson was awarded a King Charles III Coronation Medal. This was awarded from the Girl Guides of Canada for strengthening our country and helping girls and youth in our community to thrive.

Distinguished Investigator Keynote Speaker Dr. Joan Wither will be presenting at the CRA conference tomorrow Feb 28th at 4:30PM. See you there! #Rheumatology

Dr. Fadi Kharouf will be speaking tomorrow morning at 8am Feb 28th at the CRA conference. #Rheumatology

Come join us for an interesting talk by Dr. Zahi Touma tomorrow 3:30PM Feb 28th at the CRA conference. #Rheumatology

Dr. Dafna Gladman will be the keynote speaker tomorrow morning 9:30AM Feb 28th. #Rheumatology

There is an important talk by Dr. Tim Kwok happening tomorrow morning 8AM Feb 28th at the CRA conference. #Rheumatology

Come listen to a debate with Dr. Brian Feldman at the CRA conference tomorrow Feb 27th at 4pm #Rheumatology

A very informative presentation tomorrow Feb 27th at 8am by Dr. Zahi Touma at the CRA conference #Rheumatology

Plese join us tomorrow Feb 27th at 8am for a wonderful presentation by Dr. Lauren King at the CRA conference #Rheumatology

A study by Dr. Johnson, Dr. Wither and team found that most undifferentiated/asymptomatic individuals with antinuclear antibodies do not progress to a systemic autoimmune rheumatic disease over a two‐year period. pmc.ncbi.nlm.nih.gov/articles/PMC...

New study by Dr. Inman and team show that diagnostic delay continues to be a barrier to optimal care for Canadian axSpA patients. pmc.ncbi.nlm.nih.gov/articles/PMC...

Read the paper by Dr Whittall Garcia, Dr. Wither and team which provides evidence that elevated serum IFN-α levels measured at the time of an LN flare are associated with poor renal outcomes. lupus.bmj.com/content/11/2...

A study by Dr. King, Dr. Hawker and team showed that the NICE criteria have high sensitivity and specificity for detecting symptomatic knee OA in a population with type 2 diabetes. acrjournals.onlinelibrary.wiley.com/doi/10.1002/...

A study by Dr. Dafna Gladman and team found that chronic kidney disease is not infrequent in psoriatic arthritis. Its development is associated with related comorbidities, joint damage and NSAID use. Methotrexate seems to be protective. rmdopen.bmj.com/content/rmdo...